Rezultati - Barb Geiger

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors

    First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors od Filip Janků, Seung‐Hoon Beom, Yong Wha Moon, Tae Won Kim, Young G. Shin, Dong‐Seok Yim, Gun Min Kim, Hyo Song Kim, Sun Young Kim, Jae‐Ho Cheong, Young Woo Lee, Barb Geiger, Sanghee Yoo, Archie Thurston, Dean J. Welsch, Marc S. Rudoltz, Sun Young Rha

    Izdano 2022
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: